Singapore markets closed

PHAT May 2024 15.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
7.500.00 (0.00%)
At close: 10:30AM EDT
Full screen
Previous close7.50
OpenN/A
Bid0.00
Ask0.00
Strike15.00
Expiry date2024-05-17
Day's range7.50 - 7.50
Contract rangeN/A
VolumeN/A
Open interest1
  • Barrons.com

    ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors

    RA Capital increased its stake in biopharmaceutical firm ARS. Bain Capital lowered its stake in pharmaceutical firm Nuvalent.

  • GlobeNewswire

    Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference

    FLORHAM PARK, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced today that members of the management team will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024, at 9:30 a.m. ET. Company management will also participate in one-on-one meetings during the conference, wh

  • GlobeNewswire

    Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”

    National TV and digital media campaign aims to motivate millions of people suffering from Erosive GERD to learn more about VOQUEZNA® (vonoprazan), the first and only FDA-approved potassium-competitive acid blocker (PCAB) A Media Snippet accompanying this announcement is available by clicking on this link. FLORHAM PARK, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for g